Developing Novel Therapies in Coronary Vasomotor Disorders: Translational Gaps from Basic Science to Clinical Impact.

Autor: Beltrame JF; Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, Australia (J.F.B., D.P.W.); Department of Cardiology, Central Adelaide Local Health Network, Adelaide, South Australia, Australia (J.F.B.); and Basil Hetzel Institute for Translational Health Research, Adelaide, South Australia, Australia (J.F.B., D.P.W.) john.beltrame@adelaide.edu.au., Wilson DP; Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, Australia (J.F.B., D.P.W.); Department of Cardiology, Central Adelaide Local Health Network, Adelaide, South Australia, Australia (J.F.B.); and Basil Hetzel Institute for Translational Health Research, Adelaide, South Australia, Australia (J.F.B., D.P.W.).
Jazyk: angličtina
Zdroj: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2024 Aug 19; Vol. 390 (3), pp. 277-279. Date of Electronic Publication: 2024 Aug 19.
DOI: 10.1124/jpet.124.002159
Databáze: MEDLINE